Among a small cohort of children and adolescents with autism spectrum disorder, a 12-week course of memantine led to improved ...

The method used to evaluate medication efficacy in clinical trials in AD has been evolving over the last 10 years and is on the brink of further change. In the past, efficacy assessments have ...

Some people with autism spectrum disorder (ASD) have abnormal levels of glutamate in the brain. New research led by Mass General Brigham has focused on this neuron-activating chemical, suggesting that ...

USA: A recent randomized clinical trial published in JAMA Network Open suggests that memantine, a drug commonly used for ...

The second-generation cholinesterase inhibitors (donepezil, rivastigmine, and galantamine) have become standard therapy for patients with mild-to-moderate Alzheimer's disease (AD). A newer treatment ...

For decades, dementia, especially Alzheimer’s disease, was treated as untouchable. Families watched loved ones fade, doctors could offer only reassurance and coping strategies, and research seemed to ...

A class of drugs commonly used to treat Alzheimer’s disease and other dementias in nursing home residents has been found to slow cognitive decline over a five-year period in patients diagnosed with ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved ...